Talking Out Loud Podcast Ep 5 | Sonjoy Brahma & Joab Williamson By TMC|2026-10-26T13:29:09+00:0026 October 2026|Talking Out Loud|0 Comments Read More
Talking Out Loud Podcast Ep 4 | Chris Floyd & Roz Sutton By TMC|2026-10-26T13:28:31+00:0026 October 2026|Talking Out Loud|0 Comments Read More
Talking Out Loud Podcast Ep 3 | Rienk Pypstra & Mark Lemonnier By TMC|2026-10-26T13:27:46+00:0026 October 2026|Talking Out Loud|0 Comments Read More
Talking Out Loud Podcast Ep 2 | Rob Fox & Chris Floyd By TMC|2026-10-26T13:27:06+00:0026 October 2026|Talking Out Loud|0 Comments Read More
Talking Out Loud Podcast Ep 1 | Rienk Pypstra & David Findlay By TMC|2026-10-26T13:25:52+00:0026 October 2026|Talking Out Loud|0 Comments Read More
Conditional marketing authorisation in the EU: Managing the path from approval to full licence By TMC|2026-09-24T08:43:43+01:0024 September 2026|In the media|0 Comments Read More
Rare Conversations podcast: Navigating the revised UK clinical trial regulations By TMC|2026-09-23T13:37:12+01:0023 September 2026|Podcast|0 Comments Read More
UK Clinical Trial Regulation: a practical look at the 2026 reforms On 28 April 2026, the Medicines for Human Use [...] By TMC|2026-09-23T13:37:30+01:0023 September 2026|Blog|0 Comments Read More
FDA reinforces the single pivotal trial pathway for new drug approvals: what does this mean for your drug development? The US Food and Drug Administration (FDA) recently reaffirmed [...] By TMC|2026-09-17T16:14:30+01:0017 September 2026|Industry news|0 Comments Read More
TMC expands regulatory, medical and scientific expertise with acquisition of tranScrip TMC is pleased to announce that tranScrip, a specialist [...] By TMC|2026-08-14T16:30:28+01:0014 August 2026|Company news|0 Comments Read More